|
|
40
|
|
|
4181J
|
|
|
ACTEMRA 162MG/0.9ML INJ (ROC/AHI) TOCILIZUMAB
|
|
|
TOCILIZUMAB
|
|
|
ACTEMRA
|
|
|
4X0.9ML
|
|
|
C
|
|
|
706.76
|
|
|
176.69
|
|
|
162MG/0.9ML
|
|
|
INJECTION
|
|
|
0
|
|
|
AMP
|
|
|
ROC
|
|
|
ROCHE SERVICIOS S.A.
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|